Sfoglia per Rivista RADIOTHERAPY AND ONCOLOGY
Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer
2006-01-01 Guedea, F; Aguilo, F; Polo, A; Langley, S; Laing, R; Henderson, A; Aaltomaa, S; Kataja, V; Palmgren, J; Bladou, F; Salem, N; Gravis, G; Losa, A; Guazzoni, G; Nava, L
Effectiveness of an F-18-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial
2016-01-01 de Bree, R; van der Putten, L; Van Tinteren, H; Wedman, J; Oyen, W; Janssen, Lm; van den Brekel, Mwm; Comans, Efi; Pruim, J; Takes, Rp; Hobbelink, Mgg; Olmos, Rv; van der Laan, Bfam; Boers, M; Hoekstra, Os; Leemans, Cr
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer
2006-01-01 de Geus-Oei, Lf; Kaanders, Jham; Pop, Lam; Corstens, Fhm; Oyen, W
Efficacy and safety of re-irradiation of locally recurrent prostate cancer with FFF-VMAT
2017-01-01 D'Agostino, Gr; Franzese, C; Di Brina, L; Tomatis, S; Iftode, C; Franceschini, D; Clerici, E; Reggiori, G; Tozzi, A; Navarria, P; Scorsetti, M
Evaluation of a radiotherapy-dedicated Monte Carlo environment in clinical VMAT plans.
2018-01-01 Reggiori, G; Stravato, A; Paganini, L; Di Filippo, M; Fogliata, A; Palumbo, V; Mancosu, P; Tomatis, S; Scorsetti, M
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC)
2007-01-01 Bossi, P; Orlandi, E; Locati, L; Bergamini, C; Liberatoscioli, C; Fallai, C; Palazzi, M; Olmi, P; Licitra, L
FLT-PET FOR DETECTION OF EARLY TREATMENT RESPONSE IN CERVICAL LYMPH NODE METASTASES OF HEAD AND NECK TUMOURS
2010-01-01 Troost, E; Bussink, J; Oyen, W; Kaanders, J
FLT-PET IN HUMAN HEAD AND NECK CARCINOMAS: VALIDATION WITH HISTOPATHOLOGY OF SURGICAL SPECIMEN
2008-01-01 Troost, E; Hoffmann, A; Siootweg, P; Merkx, M; van Dalen, J; van der Kogel, A; Oyen, W; Kaanders, J; Bussink, J
FLT-PET-CT FOR EARLY TREATMENT RESPONSE MONITORING IN HEAD AND NECK TUMOURS
2010-01-01 Troost, E; Bussink, J; Hoffmann, A; Boerman, O; Oyen, W; Kaanders, J
Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes
2022-01-01 Guaineri, A; Maddalo, M; Bastia, Mbde; Magrini, Sm; Toraci, C; Bossi, P; Paderno, A; Maroldi, R; Ravanelli, M; Piazza, C; La Mattina, S; Facheris, G; Volpi, G; Singh, N; Pastorello, E
HIGH DOSE TOMOTHERAPY TREATMENT OF LYMPH NODAL RELAPSE IN PROSTATE CANCER
2008-01-01 Berardi, G; Alongi, F; Cozzarini, C; Landoni, C; Picchio, M; Fiorino, C; Guazzoni, G; Messa, C; Fazio, F; Di Muzio, N
High hypofractionation using beacon transponders in intermediate-risk prostate cancer: first results
2017-01-01 Di Brina, L; D'Agostino, G; Franzese, C; Franceschini, D; Comito, T; De Rose, F; Navarria, P; Tozzi, A; Iftode, C; Ascolese, A; Clerici, E; Pasini, L; Benetti, A; Scorsetti, M
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study
2008-01-01 Cozzarini, C; Fiorino, C; Di Muzio, N; Valdagni, R; Salonia, A; Alongi, F; Broggi, S; Guazzoni, G; Montorsi, F; Rigatti, P; Calandrino, R; Fazio, F
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.
2018-01-01 Navarria, P; Pessina, F; Franzese, C; Tomatis, S; Perrino, M; Cozzi, L; Simonelli, M; Bello, L; Clerici, E; Riva, M; Santoro, A; Scorsetti, M
Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis
2017-01-01 De Rose, F; Fogliata, A; Franceschini, D; Iftode, C; Ascolese, Am; Comito, T; Di Brina, L; Tozzi, A; Franzese, C; Clerici, E; D'Agostino, Gr; Navarria, P; Lobefalo, F; Scorsetti, M
Hypofractionated stereotactic RS for patients with brain metastases. Outcome evaluation and toxicity
2016-01-01 Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; DE ROSE, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M
Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity
2016-01-01 Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; De Rose, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M
HYPOFRACTIONATED TOMOTHERAPY TREATMENT (HTT) IN PROSTATE CANCER LYMPH NODAL RELAPSE DETECTED BY 11CCHOLINE PET/CT
2011-01-01 Berardi, G; Pappalardi, B; Fiorino, C; Cozzarini, C; Guazzoni, G; Calandrino, R; Di Muzio, Ng
Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients
2016-01-01 Iftode, C; De Rose, F; Franceschini, D; Fogliata, A; Villa, E; Ascolese, Am; Navarria, P; D'Agostino, Gr; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Stravato, A; Scorsetti, M
IDENTIFICATION OF RESIDUAL METABOLIC-ACTIVE AREAS WITHIN NSCLC TUMOURS USING A PRE-RADIOTHERAPY FDG-PET-CT SCAN: A PROSPECTIVE VALIDATION
2010-01-01 Aerts, H; Bussink, J; Oyen, W; van Elmpt, W; Folgering, A; Emans, D; Velders, M; De Ruysscher, D
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer | 1-gen-2006 | Guedea, F; Aguilo, F; Polo, A; Langley, S; Laing, R; Henderson, A; Aaltomaa, S; Kataja, V; Palmgren, J; Bladou, F; Salem, N; Gravis, G; Losa, A; Guazzoni, G; Nava, L | |
Effectiveness of an F-18-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial | 1-gen-2016 | de Bree, R; van der Putten, L; Van Tinteren, H; Wedman, J; Oyen, W; Janssen, Lm; van den Brekel, Mwm; Comans, Efi; Pruim, J; Takes, Rp; Hobbelink, Mgg; Olmos, Rv; van der Laan, Bfam; Boers, M; Hoekstra, Os; Leemans, Cr | |
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer | 1-gen-2006 | de Geus-Oei, Lf; Kaanders, Jham; Pop, Lam; Corstens, Fhm; Oyen, W | |
Efficacy and safety of re-irradiation of locally recurrent prostate cancer with FFF-VMAT | 1-gen-2017 | D'Agostino, Gr; Franzese, C; Di Brina, L; Tomatis, S; Iftode, C; Franceschini, D; Clerici, E; Reggiori, G; Tozzi, A; Navarria, P; Scorsetti, M | |
Evaluation of a radiotherapy-dedicated Monte Carlo environment in clinical VMAT plans. | 1-gen-2018 | Reggiori, G; Stravato, A; Paganini, L; Di Filippo, M; Fogliata, A; Palumbo, V; Mancosu, P; Tomatis, S; Scorsetti, M | |
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) | 1-gen-2007 | Bossi, P; Orlandi, E; Locati, L; Bergamini, C; Liberatoscioli, C; Fallai, C; Palazzi, M; Olmi, P; Licitra, L | |
FLT-PET FOR DETECTION OF EARLY TREATMENT RESPONSE IN CERVICAL LYMPH NODE METASTASES OF HEAD AND NECK TUMOURS | 1-gen-2010 | Troost, E; Bussink, J; Oyen, W; Kaanders, J | |
FLT-PET IN HUMAN HEAD AND NECK CARCINOMAS: VALIDATION WITH HISTOPATHOLOGY OF SURGICAL SPECIMEN | 1-gen-2008 | Troost, E; Hoffmann, A; Siootweg, P; Merkx, M; van Dalen, J; van der Kogel, A; Oyen, W; Kaanders, J; Bussink, J | |
FLT-PET-CT FOR EARLY TREATMENT RESPONSE MONITORING IN HEAD AND NECK TUMOURS | 1-gen-2010 | Troost, E; Bussink, J; Hoffmann, A; Boerman, O; Oyen, W; Kaanders, J | |
Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes | 1-gen-2022 | Guaineri, A; Maddalo, M; Bastia, Mbde; Magrini, Sm; Toraci, C; Bossi, P; Paderno, A; Maroldi, R; Ravanelli, M; Piazza, C; La Mattina, S; Facheris, G; Volpi, G; Singh, N; Pastorello, E | |
HIGH DOSE TOMOTHERAPY TREATMENT OF LYMPH NODAL RELAPSE IN PROSTATE CANCER | 1-gen-2008 | Berardi, G; Alongi, F; Cozzarini, C; Landoni, C; Picchio, M; Fiorino, C; Guazzoni, G; Messa, C; Fazio, F; Di Muzio, N | |
High hypofractionation using beacon transponders in intermediate-risk prostate cancer: first results | 1-gen-2017 | Di Brina, L; D'Agostino, G; Franzese, C; Franceschini, D; Comito, T; De Rose, F; Navarria, P; Tozzi, A; Iftode, C; Ascolese, A; Clerici, E; Pasini, L; Benetti, A; Scorsetti, M | |
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study | 1-gen-2008 | Cozzarini, C; Fiorino, C; Di Muzio, N; Valdagni, R; Salonia, A; Alongi, F; Broggi, S; Guazzoni, G; Montorsi, F; Rigatti, P; Calandrino, R; Fazio, F | |
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. | 1-gen-2018 | Navarria, P; Pessina, F; Franzese, C; Tomatis, S; Perrino, M; Cozzi, L; Simonelli, M; Bello, L; Clerici, E; Riva, M; Santoro, A; Scorsetti, M | |
Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis | 1-gen-2017 | De Rose, F; Fogliata, A; Franceschini, D; Iftode, C; Ascolese, Am; Comito, T; Di Brina, L; Tozzi, A; Franzese, C; Clerici, E; D'Agostino, Gr; Navarria, P; Lobefalo, F; Scorsetti, M | |
Hypofractionated stereotactic RS for patients with brain metastases. Outcome evaluation and toxicity | 1-gen-2016 | Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; DE ROSE, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M | |
Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity | 1-gen-2016 | Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; De Rose, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M | |
HYPOFRACTIONATED TOMOTHERAPY TREATMENT (HTT) IN PROSTATE CANCER LYMPH NODAL RELAPSE DETECTED BY 11CCHOLINE PET/CT | 1-gen-2011 | Berardi, G; Pappalardi, B; Fiorino, C; Cozzarini, C; Guazzoni, G; Calandrino, R; Di Muzio, Ng | |
Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients | 1-gen-2016 | Iftode, C; De Rose, F; Franceschini, D; Fogliata, A; Villa, E; Ascolese, Am; Navarria, P; D'Agostino, Gr; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Stravato, A; Scorsetti, M | |
IDENTIFICATION OF RESIDUAL METABOLIC-ACTIVE AREAS WITHIN NSCLC TUMOURS USING A PRE-RADIOTHERAPY FDG-PET-CT SCAN: A PROSPECTIVE VALIDATION | 1-gen-2010 | Aerts, H; Bussink, J; Oyen, W; van Elmpt, W; Folgering, A; Emans, D; Velders, M; De Ruysscher, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile